Thrombopoietin and its receptor (MPL) are important regulators of megakaryopoiesis. We have identified an activating mutation of MPL using a combination of a retrovirus-mediated gene transfer and polymerase chain reaction-driven random mutagenesis. This point mutation causes a single amino acid substitution from Sef'= to Asn4= in the transmembrane region and abrogates factor-dependency of all interleukin-3-dependent cell lines tested. Murine interleu-
form of c-mpl fused to the env gene of MPLV.3-5 Although the ligand for MPL was not known, it was thought to be a cytokine with thrombopoietic activity because MPL is highly expressed in megakaryocytes and platelets. Moreover, antisense oligonucleotides of MPL specifically inhibited formation of megakaryocytes colonies in vitro. 6 Recently, several groups, using different strategies, successfully cloned the ligand for MPL."" The recombinant MPL ligand is a potent stimulator of megakaryopoiesis both in vivo and in vitro'"'; therefore, the MPL ligand has been named thrombopoietin (TPO). Targeted disruption of c-mpl in mice resulted in a profound decrease in the number of platelets, further indicating that the TPO/MPL system is an important regulator of megakaryopoiesis in vivo. I2 Because activating mutations have been reported in the receptor for erythropoietin (EpoR)," which is closely related to MPL, we were interested in whether activating mutations could be identified in MPL. The activating mutation of EpoR was identified by generating recombinant retroviruses through repeated infection of a retrovirus construct encoding EpoR between ecotropic and amphotropic packaging cells, which resulted in random mutations of the amplified EpoR."
In this report, we have identified an activating mutation of MPL by using polymerase chain reaction (PCR)-driven random mutagenesis and high-efficiency retrovirus packaging using the BOSC23 cell line.I4 The activating mutation causes an amino acid substitution in the transmembrane region and abrogates the interleukin-3 (IL-3) dependency of hematopoietic cell lines. In addition, we also compared the signal transduction pathways activated by normal and mutant MPL (MPL') and found that the MPL" constitutively activates the SHC-Raf-MAP kinase (MAPK) and the JAKZ-STAT3,5 pathways.
M MATERIALS AND METHODS

Reagents. Antibodies directed against phosphotyrosine
(4G10), TYK2, JAKI, JAK2, JAK3, STAT3, and SHC, were purchased from UBI (Lake Placid, NY). Anti-MAPK, anti-Raf-l, and anti-MPL antibodies were purchased from Zymed Laboratories Inc (South San Francisco, CA), Santa Cruz Biotechnology (Santa Cruz, CA), and Genzyme (Cambridge, MA), respectively. Polyclonal chicken antibodies raised against the N-terminal 120-amino-acid region of sheep STAT5 were described previously." Recombinant human TPO (hTP0) was a generous gift from Dr M. Tsang (R & D Systems, Minneapolis, MN). Recombinant murine IL-3 (mIL-3) was produced and purified as described previously.'' All restriction endonucleases were purchased from New England Biolabs (Beverly, MA).
Cell lines and cell culture. B e 3 cells" were maintained in RPM1 1640 medium supplemented with 10% fetal calf serum (FCS), 2 mmol/L glutamine, 100 U/mL penicillin and 100 pg/mL streptomycin, and 10 ng/mL mIL-3. An ecotropic retrovirus packaging cell line BOSC23 (ATCC CRL 11270; American Type Culture Collection [ATCC], Rockville, MD)'4 was maintained in Dulbecco's modified Eagle's medium (DMEM) containing IO% FCS (DMEM/ 10%FCS) and guanine phosphoribosyl transferase (GPT) selection reagents (Specialty Media, Lavallette, NI). The cells were transferred into DMEM/IO% FCS without GPT selection reagents 2 days before transfection.
Construction of a retroviral vector carrying the wild-type MPL (MPLW).
A cDNA for MPL was cloned from a cDNA library of a human erythroid TF-I cell line'* using PCR primers based on the published sequence.' Briefly, we used pfu polymerase (Stratagene, La Jolla, CA) to amplify two overlapping PCR fragments. The full coding region of human MPL was reconstructed from these two fragments, and inserted into EcoRI sites of the pBabeX retroviral vector." The MPL sequence derived from TF-I cells was identical to that of the published sequence.
PCR. To introduce random mutations, the PCR was run for 35 cycles (1 minute at 94°C for denaturation, 2 minutes at 59°C for annealing, and 3 minutes at 72°C for extention) using a DNA Thermal Cycler (Perkin-Elmer-Cetus, Branchburg, NJ) under the standard conditions except for the varied concentrations of deoxynucleotide 1.0 mmol/L of dNTPs did not work efficiently. We used 0.2 or 0.6 mmol/L of dNTPs for further experiments. The primers were chosen to amplify the segment spanning the second cytokine receptor domain, the transmembrane domain, and the membrane proximal region of the cytoplasmic domain (Fig I) . The PCR product was digested with restriction endonucleases, Hind111 and Avr 11, and the 0.9-kb HindIII-Avr 11 fragment was ligated to the Hind111 and Avr I1 sites of the pBabeX-MPL. The mixture of the ligated plasmids was amplified in Escherichitr coli DHSa, and the plasmid DNA was prepared using Qiagen Maxi prep kit (Qiagen, Chatsworth, CA).
Prepration of high-titer retroviruses m d ir$xtiorz o f B d F 3 crlls. High-titer retroviruses carrying randomly mutated MPL sequences were produced using a packaging cell line BOSC23 and were infected into BdF3 cells as described previously.'" Briefly, 3 pg of the retrovirus DNA constructs carrying MPL with random mutations prepared as described above were transfected into BOSC23 cells ( 2 X IO6 cells in a 60-mm culture dish) using Lipofectamine (GIBCO-BRL, Grand Island, NY). Two days after the transfection, the supernatant containing retroviruses was collected. For infection. BaF3 cells ( I X 10' ) were incubated with 3 mL of virus supernatant in the presence of 10 pg/mL polybrene and 10 ng/mL mIL-3. After 8 hours, 3 mL of fresh growth media was added to the culture, and the incubation was extended for 16 hours. Under these conditions, infection efficiency of BalF3 cells is 10% to 20%).
PuriJicatiorz of genomic DNA. Genomic DNAs were extracted from the factor-independent Ba/F3 clones as follows. One to five million cells were collected; washed once with phosphate-buffered saline (PBS); lysed in 500 p L lysis buffer containing 50 mmol/L NaCI, 10 mmol/L Tris-HCI (pH, 7.5), 5 mmol/L EDTA (pH, 8.0). 0.2% sodium dodecyl sulfate; and incubated with 100 pg/mL proteinase K for 3 to 16 hours, followed by phenol-chloroform extraction. The DNA was precipitated in 70% ethanol in the presence of 1 0 0 mmol/L NaCI, washed once with 70% and once with 100% ethanol. dried at room temperature. and resuspended in TE buffer (IO mmol/L Tris-HCI [pH. 7.51 and I mmol/L EDTA).
Seqwncirlg qj"r/rrtrovirrt//y irrtrorlrcc.rc/ MPL. The integrated MPL sequences were recovered from factor-independent BdF.1 clones by PCR using 10 ng of genomic DNAs and internal MPL primers ( Fig  I ) under the same conditions as described above exccpt for the reduced concentrations (0. I mmol/L) of dNTPs. The resulting PCR fragments were puritied from an agarose gel using QIAEX (Qiagen) and were sequenced for screening. Then, for confirmation of the detected mutations, each PCR fragment from the hulh products was cloned into the TA vector, and multiple TA clones were bequenued. Sequencing reaction was performed using Tu4 DyeDeoxy Terminator Cycle Sequencing Kit (Applied Biosystems. Menlo Park, CA). and then the sequence was analyzed on an Applied Biosy\tcms model 173A sequencer.
Crllprolifrrtltiorl trs.str?. To quantitate cell proliferation. we used thc Alamar Blue assay (Alamar Biosciences Inc. Sacramento. CA) as previously described.20 Briefly. 2 X 1 0 ' BdF3 cells were buspended in 1 0 0 pL of the medium supplemented with 0.5% bovine serum albumin (BSA) and were cultured in 96-well microtiter plates lor 48 hours at 37°C i n the presence or absence of various concentrations of hTPO. Alamar Blue solution (10 pL) was then added to each well. and the incubation was extended for another 24 hours. Thc optical density was measured on an enzyme-linked irnmunosorbent assay microplate reader with a test wavelength of 570 n m and a reference wavelength of 600 nm.
Comtnrctiorl o f retrcn.iml ~'e('tor c.crrrl.irlg the rtlurnrrd MPL.. We subcloned a PCR product containig the mutation in the transmembrane region into the TA cloning vector pCRll (Invitrogen. San Diego. CA). picked several clones, and confirmed the sequence of these clones to exclude de novo mutations during the PCR amplitication. Then, a Rgl 11-Avr II fragment (0.4 kb) carrying only this mutation was excised from one of the TA clones. and was inserted into the BR/ II-ALY 11 sites of the original pBabeX-MPL.
Irnr,lurzoprPcil,itcrtiorl c m / Wester12 hlottirrg. Exponentially growing cells were washed free of serum and growth factors and were incubated in RPM11640 supplemented with 0.5% BSA for 12 hours at 37°C. After this depletion period, the cell5 were rewspended i n the same media at a concentration o f 3 X IO"/mL and were stimulated with I O ng/mL m1L-3 or 100 ng/mL hTPO at 37°C for I O minutes. The cells were then washed with ice-cold PBS and lysed in a buffer containing 50 nnnol/L HEPES (pH, 7.5). 100 mmol/L NaF. 10 mmol/L sodium pyrophosphate.
2 mmol/L NaVO,. 3 mmol/L EDTA. 2 mmol/L NaMnO,. 0.2 mol/L Pefabloc (Boehringer Mannheim. Indianapolis. IN), 2 pg/mL leupeptin, and I O pg/mL aprotinin using I ml, lysis buffer for 2 X 10' cell^.^' Insoluble material was removed by centrifugation at 10,0001: for 15 minutes at 4°C. Immunoprecipitation. gel electrophoresis. and immunoblotting were performed according to methods described previously." with minor modificationh. Briefly, the lysates were incubated at 4°C overnight with the appropriate primary antibodies and protein A Sepharose to collect antigen-antibody complexes. The immunoprecipitates were washed 4 times with lysis buffer and subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Proteins were then electrophoretically transferred onto polyvinylidene fluoride (PVDF) Immobilon tilter.; (Milliporc, Bedford. MA). After incubating filters in blocking solution containing 3.0% BSA.
5 0 mmol/L Tris-HCI (pH, 7.5). 150 mn~ol/L NaCI, and 0. I % sodium alide, the tilters were probed with antiphosphotyrosine (4G10). These tilters were stripped and reprobed with anti-SHC. anti-JAKI. anti-JAK2. anti-JAK3, anti-TYK2, anti-STAT3, or anti-STATS antibodies to asmre equal loading in each lane of the gel.
In some experiments, total lysates were electrophoresed o n sodium dodecyl sulfate-polyacrylamide gel electrophoresis. transferred onto Immobilon tilters. and probed with either anti-MPL, anti-Raf-l, or
For personal use only. on August 28, 2017 . by guest www.bloodjournal.org From anti-MAPK antibodies. The bound antibody complexes on the filters were visualized using the enhanced chemiluminescence system (Amersham, Arlington Heights, IL).
RESULTS
Isolation of a constitutively activated form of MPL. To isolate activating forms of MPL, we introduced random mutations into the MPL sequence by PCR using Taq polymerase as described in Materials and Methods. Several of the resulting plasmids were picked at random and the 0.9-kb region that had been amplified by PCR was sequenced. The average number of the mutations in this region of each clone was 0.8. Therefore, the resulting plasmid DNA can be considered a library of MPL with random mutations in the 0.9-kb HindIII-Avr I1 fragment encoding the second cytokine receptor domain, the transmembrane domain, and the membrane proximal region of the cytoplasmic domain (Fig 1) . This library contained 2.0 X IO4 independent clones, and there was no apparent bias in the type of mutation observed (data not shown). Therefore, assuming that there is no difference in the frequency of mutation at each base, the library should cover all possible mutations in the 0.9-kb sequence that was amplified by PCR. Transfection of the randomly mutated MPL into BOSC23 cells14 gave rise to high-titer retroviruses (> 106/mL),'9 which is fully representative of the MPL library described above. The resulting retroviruses were then infected into an mIL-3-dependent cell line, B d F3. Some of the infected Ba/F3 cells survived in the absence of mIL-3 and started growing in several days. A total of 24 IL-3-independent Ba/F3 cells was cloned by limiting dilution using 96-well multititer plates.
identijkation of an activating mutation in MPL. Multiple TA clones were recovered from retrovirally transduced MPL sequences from the IL-3-independent Ba/F3 clones as described in the Materials and Methods. The TA clones from 10 of 24 IL-3-independent BdF3 cells analyzed had the same point mutation (G to A) in sequences encoding the transmembrane region of MPL that gave rise to an amino acid substitution of Ser498 to (Fig 2) . From 1 of the 10 IL-3-independent clones with the mutation, we also cloned an MPL integration with no mutation, indicating that this particular clone has two MPL integrations, one with and the other without the mutation. To confirm that this mutation of MPL was sufficient to cause constitutive activation of MPL, we introduced this point mutation into c-MPL (see Materials and Methods). Infection of Ba/ F3 cells with the retrovirus construct carrying c-MPL with the mutation (designated MPLM) resulted in IL-3-independent growth of 10% to 20% of the infected BdF3. Taking into account the general infection efficiency of B d F3 cells with pBabeX vector (10% to 2O%),I9 this result suggested that the mutation of the MPL transmembrane indeed induced IL-3-independent growth of the infected BdF3 cells. In addition, we showed that the MPLM could abrogate IL-3 dependency of several other cell lines including TF-I ," FDC-PI ," and OTT-1 . 23 Although we detected other point mutations from factorindependent clones (10 of 24) established from BaR3 cells infected with the retroviruses carrying randomly mutated MPL sequences, 8 of these other mutations did not cause amino acid substitutions, whereas 2 mutations that did result in amino acid substitutions did not reproduce the IL-3-independent phenotype when reintroduced into Ba/F3 cells. Of the remaining 4 clones, which did not show any mutations in the amplified MPL sequence, 1 clone was producing endogenous TPO, perhaps because of promoter insertion. In summary, 14 of 24 IL-3-independent cell clones were experimental backgrounds probably caused by retroviral insertional mutagenesis, 1 of which was likely because of the autocrine TPO production.*
Generation of B d F 3 cells expressing either the mutant or wild-type MPL.
To compare the function of MPLM and the MPLW, we established BaF3 clones that stably express either MPLM or MPLW. B e 3 cells infected with retroviruses encoding either MPLM or MPLW and the puromycin-resistance gene.24 A total of 12 BaR3 clones expressing MPLM (Ml-M12) and 10 BafF3 clones expressing MPLW (Wl-W10) was isolated by limiting dilution, and these clones were tested for expression of MPL by Western blot analysis (Fig 3) and for the factor-responsiveness in the Alamar Blue assay (Fig 4 and data not shown) .
All Ba/F3 clones expressing the MPLW (W1 to W10) were growth factor-dependent and required either mIL-3 or hTPO for growth. In contrast, all Ba/F3 clones expressing MPLM (M1 to M12) proliferated in the absence of L -3 and even in the absence of FCS. The results of the proliferation assay for representative clones are shown in Fig 4. All IL-3-independent Ba/F3 clones expressing MPLM, except for the clone M3, still retain a response to exogeneously added hTP0. Clone M3, the highest expresser of MPLM, proliferates at a maximum rate even in the absence of hTPO thus, its growth is not further enhanced by the addition of hTPO (Fig 4B) . The conditioned media of these cells was analyzed for the presence of mIL-3 or hTPO, but neither of these factors could be detected (data not shown).
For further analysis, clones W6, M3, and M10 were chosen. W6 and M10 express a similar amount of the MPLW and the MPLM, respectively, and proliferation of these clones was enhanced by exogeneously added hTPO, whereas M3 expressed the highest levels of MPLM (Fig 3) and proliferated normally in the absence of hTPO (Fig 4B) .
Signal transduction pathways activated by MPL. Two major signal transduction pathways downstream of cytokine receptors have been extensively characterized, ie, SHC-RasRaf-MAPK cascade and the recently identified JAK-STAT path~ay.'~-~* To investigate the signaling pathways activated by MPLW and MPLM, clones W6, M3, and M10 and parental Ba/F3 cells were stimulated with either hTPO or mIL-3, and the activation of these pathways was assessed either by alteration in tyrosine phosphorylation state (SHC, JAK2, TYK2, STAT3, and STAT5) or by their change in electrophoretic mobility (Raf and MAPK).
In both parental Ba/F3 cells and Ba/F3 clones expressing the MPLw, the addition of mIL-3 stimulated the tyrosine phosphorylation of SHC and induced an electrophoretic mobility shift of Raf-l and p42 MAPK:9-3' phosphorylation of JAK2, STAT3, and STAT52'.32. 33 Fig  5) were observed even without cytokine stimulation in M3 and M10, and the extent of activation was similar to that observed with either mIL-3 or hTPO stimulation. Constitutive phosphorylation of JAK2, STAT3, and STAT5 was also detected (Fig  6) . However, unlike SHC, Raf, and MAPK, the levels of phosphorylation of JAWSTATs were considerably lower than those observed in factor-stimulated cells. Phosphorylation of these proteins could be enhanced by the addition of mIL-3 or hTP0. Phosphorylation of JAKl and JAK3 were not observed under any conditions described herein (data not shown), which is consistent with the results of recent r e p~r t s .~.~~ To assess the tumorigenicity of B e 3 cells expressing MPLM, we injected 3 million cells of parental Ba/F3, B e 3 cells expressing normal MPL (W6 or W7), or Ba/F3 cells expressing the mutant MPL (M3 or M10) into syngeneic BALBk mice. Histopathological studies after 3 weeks of the injection showed remarkable infiltration of tumor cells in the lung, liver, spleen, and bone marrow of the mice injected with M3 or M10. Mice injected with Ba/F3, W6, or W7 showed no obvious pathological findings in any of the organs described above (data not shown). Table 1 shows the estimated percentages of the infiltrated tumor cells in spleen and bone marrow that were calculated from the forward scatter and the side scatter patterns on fluorescenceactivated cell sorter analysis; B e 3 cells are bigger than mouse spleen or bone marrow cells. Mice inoculated with M3 or M10 developed a huge splenomegaly, and the weight of the spleens was at least 10 times greater than that from the mice injected with Ba/F3, W6, or W7 ( Table 1) (lanes 1-10) or MPLM (lanes [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] were subjected to Western blot analysis using an MPL antibody (Genzyme). Clones that were tested for proliferation in the presence or absence of hTPO (see Fig 4) Concentrations of TPO (nglml) 
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DISCUSSION
We have recently established a method of expression cloning using retrovirus cDNA libraries." We have applied this system, in combination with PCR-driven mutagenesis, to 1403 search for activating mutations of the receptors for TPO, c-MPL, and have identified one such mutation. This mutation gave rise to an amino acid substitution from Ser to Asn in the transmembrane domain of the protein. This activated form of MPL converted several IL-3-dependent cell lines to factor independence. Ba/F3 cells expressing the MPLM were able to proliferate in the absence of both cytokines and serum, and the growth rates under these conditions correlated with the expression levels of the mutant MPL.
Our results indicated that the MPLM constitutively activated signal transduction pathways in B e 3 cells that can also be activated by the normal MPL.34-37 The process by which the amino acid substitution in the MPLM leads to constitutive activation is not clear; however, one possibility is that this mutation induces receptor homodimerization. Ligand-induced homodimerization or heterodimerization is believed to be a requisite step for activation of tyrosine kinase receptors." In fact, constitutive activation of c-kit and Neu result from a mutation that leads to constitutive dimerization of these Similarly, constitutively activated cytokine receptors such as EpoR and the common p subunit of the IL-3, granulocyte/macrophage colony-stimulating factor (GM-CSF), and IL-5 receptors have been des~ribed.".~'.~' Although we could not show constitutive dimerization of the MPLM molecule, we believe that this is very likely occurring for two reasons. First, we observed oligomerization of the MPLW on ligand stimulation (data not shown). Second, the point mutations that induce constitutive dimerization of ckit3' and Neu4' locate in the transmembrane domain similar to the activating mutation of MPL. Therefore, the substitution in the transmembrane region of the MPLM may similarly lead to constitutive homodimerization of MPL.
To gain insight into the mechanism by which the MPLM converts cells to factor independency, several intracellular signaling events were examined. One pathway, the SHCRaf-MAPK cascade, was constitutively activated in cells expressing the MPLM. The extent, both of SHC tyrosine phosphorylation and Raf or MAPK mobility shift resembled those of mIL-3-or hTPO-stimulated cells. In contrast, although a low level of JAK2, STAT3, and STAT5 tyrosine phosphorylation occurred constitutively, the levels observed were a fraction of that observed with TPO stimulation. These data suggest that full activation of the SHC-Raf-MAPK pathway is important to the ability of MPLM to support Ba/F3 cell growth. On the other hand, the low level of constitutive tyrosine phosphorylation of JAK2, STAT3, and STAT5 downstream of the mutant MPL suggests either that this pathway is not essential or that the small degree of activation observed is sufficient for the MPLM to stimulate proliferation. The latter possibility is supported by our recent results that a dominant negative form of STAT5 inhibits IL-3- The results shown are the average of three mice t SD.
associates with the y -~h a i n .~.~' The observed activation of JAK2 but not TYK2 suggests that MPL associates with JAK2, whereas a putative second subunit binds to TYK2. Therefore, the presumed homodimerization of the MPLM leads to activation of JAK2 in the absence of TYK2.
Further work is necessary to clarify the mechanism by which MPLM exerts its proliferative action. However, as the studies reported in this article show, the mutations of signaling molecules that alter the function of the molecules have the potential to give new insight into their mode of action. PCR-driven random mutagenesis and retrovirus-mediated gene transfer provides an efficient way to screen for these interesting mutations.
During the preparation of this report, Jenkins et a14' have reported identification of activating mutations in the common / 3 subunit of the human IL-3, GM-CSF, and IL-5 receptors using a similar strategy with that described in this report.
NOTE ADDED IN PROOF
After the submission of our paper, Alexander et a149 reported identification of activating mutations of MPL in the extracellular domain by site-directed mutagenesis.
